Implantable electrodes containing polyoxometalate anions and methods of manufacture and use

Patent metadata

Field	Value
Publication number	US-9364678-B2
Application number	US-201113166528-A
Country	US
Kind code	B2
Filing date	Jun 22, 2011
Priority date	Dec 21, 2006
Publication date	Jun 14, 2016
Grant date	Jun 14, 2016

Abstract

An implantable device includes at least one electrode comprising a conductive base and polyoxometalate anions disposed on or within the conductive base; and at least one conductor attached to the at least one electrode for conducting electrical energy to the at least one electrode.

First claim

What is claimed and desired to be protected by Letters Patent of the United States is:

1. An implantable lead, comprising:
an elongate lead body comprising a distal portion and a proximal portion;
a plurality of electrodes disposed on the distal portion of the lead body, at least one of the electrodes comprising a conductive base and polyoxometalate anions disposed on or within the conductive base, wherein the polyoxometalate anions comprise anions having the formula [X x M y Q w O z ] q− or the formula [X x M y Q w O z R r ] q− wherein M and Q are independently selected from Ta, V, Mo, Co, Cr, Ni, Nb, W, Ti, Fe, Ir, Ru, Zr, Mn, Zn, Pd, Sn, Pt, or Cu; X is selected from P, Si, B, Ge, As, or Sb; R is a covalently bonded substituent; x, y, w, z, and r are integers, wherein y and z are at least 5 and x, w, and r are at least 0; and q is an integer that represents the charge of the anion; and
a plurality of conductors disposed in the lead body and attached to the plurality of electrodes for conducting electrical energy to the plurality of electrodes for stimulation of adjacent tissue when implanted.

2. The implantable lead of claim 1 , wherein the lead is a percutaneous lead with the plurality of electrodes arranged sequentially along the distal portion of the lead body.

3. The implantable lead of claim 1 , wherein the lead is a paddle lead comprising an array body at the distal portion of the lead body, wherein the plurality of electrodes are arranged as an array on the array body.

4. The implantable lead of claim 1 , further comprising a coating disposed on the conductive base, wherein at least a portion of the polyoxornetalate anions are dispersed in the coating.

5. The implantable lead of claim 4 , wherein the coating comprises a conductive polymer carrier within which the portion of the polyoxometalate anions are dispersed.

6. The implantable lead of claim 5 , wherein the conductive polymer carrier is selected from polypyrrole, polythiophene, polyaniline, polyfurane, polyacetylene, polyetherimide, poly(diallyldimethylammonium chloride), poly(allylamine hydrochloride), chitosan, or polylysine.

7. The implantable lead of claim 1 , wherein at least a portion of the polyoxometalate anions are dispersed within the conductive base.

8. The implantable lead of claim 1 , wherein at least a portion of the polyoxometalate anions are attached to a surface of the conductive base.

9. The implantable lead of claim 1 , wherein each of the electrodes comprises the conductive base and the polyoxometalate anions.

10. The implantable lead of claim 1 , wherein the plurality of electrodes form an array.

11. A method of stimulating tissue, the method comprising:
implanting an electrode into tissue, the electrode comprising a conductive base and polyoxometalate anions disposed on or within the conductive base, wherein the polyoxometalate anions comprise anions having the formula [X x M y Q w O z ] q− or the formula [X x M y Q w O r ] q− wherein M and Q are independently selected from Ta, V, Mo, Co, Cr, Ni, Nb, W, Ti, Fe, Ir, Ru, Zr, Mn, Zn, Pd, Sn, Pt, or Cu; X is selected from P, Si, B, Ge, As, or Sb; R is a covalently bonded substituent; x, y, w, z, and r are integers, wherein y and z are at least 5 and x, w, and r are at least 0; and q is an integer that represents the charge of the anion;
coupling the electrode to a power source and an electronic subassembly configured and arranged to control delivery of electrical energy from the power source to the electrode; and
delivering electrical energy from the power source to the electrode to stimulate the tissue.

12. The method of claim 11 , wherein the electrode is disposed on an implantable lead, wherein implanting the electrode into tissue comprises implanting the implantable lead with the electrode into tissue.

13. The method of claim 11 , wherein a control module comprises the power source and the electronic subassembly.

14. The method of claim 13 , further comprising implanting the control module.

15. The method of claim 11 , wherein a microstimulator comprises the electrode, the power source, and the electronic subassembly, wherein implanting the electrode into tissue comprises implanting the microstimulator into tissue.

16. An impiantabie electrode, comprising:
a conductive base; and
polyoxometalate anions disposed on or within the conductive base, wherein the polyoxometalate anions comprise anions having the formula [X x M y Q w O z ] q− or the formula [X x M y Q w O z R r ] q− wherein M and Q are independently selected from Ta, V, Mo, Co, Cr, Ni, Nb, W, Ti, Fe, It, Ru, Zr, Mn, Zn, Pd, Sn, Pt, or Cu; X is selected from P, Si, B, Ge, As, or Sb; R is a covalently bonded substituent; x, y, w, z, and r are integers, wherein y and z are at least 5 and x, w, and r are at least 0; and q is an integer that represents the charge of the anion;
wherein the electrode is configured and arranged for implantation into a patient for delivery of electrical stimulation to tissue of the patient adjacent the electrode.

17. The electrode of claim 16 , further comprising a coating disposed on the conductive base, wherein at least a portion of the polyoxometalate anions are dispersed in the coating.

18. The electrode of claim 17 , wherein the coating comprises a conductive polymer carrier within which the portion of the polyoxometalate anions are dispersed.

19. The electrode of claim 16 , wherein at least a portion of the polyoxometalate anions are dispersed within the conductive base.

20. The electrode of claim 16 , wherein at least a portion of the polyoxemetalate anions are attached to a surface of the conductive base.

Assignees

• Atanasoska Liliana
• Weber Jan
• Schewe Scott
• Warner Robert W
• Boston Scient Neuromodulation

Inventors

• Atanasoska Liliana
• Weber Jan
• Schewe Scott
• Warner Robert W

Classifications

• A61N1/36

  for stimulation · CPC title

• A61N1/0551

  Spinal or peripheral nerve electrodes · CPC title

• A61N1/05

  for implantation or insertion into the body, e.g. heart electrode (A61N1/06 takes precedence) · CPC title

• A61N1/0553

  Paddle shaped electrodes, e.g. for laminotomy · CPC title

• A61N1/37205

  Microstimulators, e.g. implantable through a cannula · CPC title